BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15149691)

  • 21. Quantitative structure-activity relationship (QSAR) studies on a series of 1,3,4-thiadiazole-2-thione derivatives as tumor-associated carbonic anhydrase IX inhibitors.
    Abdel-Hamid MK; Abdel-Hafez AA; El-Koussi NA; Mahfouz NM
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):722-9. PubMed ID: 18720193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.
    Bertucci A; Innocenti A; Zoccola D; Scozzafava A; Tambutté S; Supuran CT
    Bioorg Med Chem; 2009 Jul; 17(14):5054-8. PubMed ID: 19520577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbonic anhydrase inhibitors: transepithelial transport of thioureido sulfonamide inhibitors of the cancer-associated isozyme IX is dependent on efflux transporters.
    Vullo D; Steffansen B; Brodin B; Supuran CT; Scozzafava A; Nielsen CU
    Bioorg Med Chem; 2006 Apr; 14(7):2418-27. PubMed ID: 16321542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
    Vullo D; Innocenti A; Nishimori I; Pastorek J; Scozzafava A; Pastoreková S; Supuran CT
    Bioorg Med Chem Lett; 2005 Feb; 15(4):963-9. PubMed ID: 15686894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QSAR studies on carbonic anhydrase inhibitors: a case of ureido and thioureido derivatives of aromatic/heterocyclic sulfonamides.
    Agrawal VK; Sharma R; Khadikar PV
    Bioorg Med Chem; 2002 Sep; 10(9):2993-9. PubMed ID: 12110322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides.
    Cecchi A; Taylor SD; Liu Y; Hill B; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5192-6. PubMed ID: 16203142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of small molecule carbonic anhydrase IX inhibitors.
    Supuran CT
    BJU Int; 2008 Jun; 101 Suppl 4():39-40. PubMed ID: 18430122
    [No Abstract]   [Full Text] [Related]  

  • 28. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Szafrański K; Vullo D; Supuran CT
    Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.
    Winum JY; Dogné JM; Casini A; de Leval X; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    J Med Chem; 2005 Mar; 48(6):2121-5. PubMed ID: 15771455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozymes IX and XII with a library of aromatic and heteroaromatic sulfonamides.
    Ozensoy O; Puccetti L; Fasolis G; Arslan O; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4862-6. PubMed ID: 16168653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
    Cecchi A; Hulikova A; Pastorek J; Pastoreková S; Scozzafava A; Winum JY; Montero JL; Supuran CT
    J Med Chem; 2005 Jul; 48(15):4834-41. PubMed ID: 16033263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A QSAR study on novel series of carbonic anhydrase inhibitors hCA IX--tumor-associated (hypoxia).
    Singh S
    Med Chem; 2012 Jul; 8(4):656-72. PubMed ID: 22548333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemometric modeling of breast cancer associated carbonic anhydrase IX inhibitors belonging to the ureido-substituted benzene sulfonamide class.
    Singh S; Supuran CT
    J Enzyme Inhib Med Chem; 2014 Dec; 29(6):877-83. PubMed ID: 24517369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.
    Nishimori I; Vullo D; Innocenti A; Scozzafava A; Mastrolorenzo A; Supuran CT
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3828-33. PubMed ID: 16039848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors.
    Morris JC; Chiche J; Grellier C; Lopez M; Bornaghi LF; Maresca A; Supuran CT; Pouysségur J; Poulsen SA
    J Med Chem; 2011 Oct; 54(19):6905-18. PubMed ID: 21851094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents.
    Agrawal VK; Bano S; Supuran CT; Khadikar PV
    Eur J Med Chem; 2004 Jul; 39(7):593-600. PubMed ID: 15236839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A physically interpretable quantum-theoretic QSAR for some carbonic anhydrase inhibitors with diverse aromatic rings, obtained by a new QSAR procedure.
    Clare BW; Supuran CT
    Bioorg Med Chem; 2005 Mar; 13(6):2197-211. PubMed ID: 15727872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbonic anhydrase inhibitors: copper(II) complexes of polyamino-polycarboxylamido aromatic/heterocyclic sulfonamides are very potent inhibitors of the tumor-associated isoforms IX and XII.
    Rami M; Winum JY; Innocenti A; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2008 Jan; 18(2):836-41. PubMed ID: 18042384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
    Almajan GL; Innocenti A; Puccetti L; Manole G; Barbuceanu S; Saramet I; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2347-52. PubMed ID: 15837323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.